SLC6A4 and pulmonary arterial hypertension: The existing literature is still controversial regarding the role of SERT gene mutations in the pathogenesis, but data supporting this has cited gain of function polymorphisms in SERT (SERT promotor L/S gene polymorphisms) in some patients—however, this was not observed uniformly in other patients with PAH [66,67].